Intravenous Solution Compounders Market Overview Intravenous medication is one of the crucial aspects of hospital and pharmacy, and preparation of these requires utter precision as the patient’s wellbeing is directly affected by the compounded preparations. Increasing intravenous preparations use in hospitals is increasing the demand for intravenous solution compounders. Intravenous solution compounders are choice of instrument …
Category Archives: Healthcare Trends
Ultrasonic Surgical Cutters Market Product Scope, Total Revenues, Business Development and Opportunities till 2028
Ultrasonic surgical cutters are also referred to as harmonic scalpel and it is the handheld surgical medical equipment which is used during the surgery for cutting the tissue. Ultrasonic surgical cutters is powered with battery or electrically. The frontal end of ultrasonic surgical cutters is enabled with a blade and temporal end is equipped with …
Softgel Capsules Market to reach a valuation of ~US$ 3.1 Billion by 2032
[Report of 250 Pages] The market for softgel capsules is anticipated to reach a value of US$ 1.7 billion by the end of 2022 and to grow at a CAGR of 6.0% to reach US$ 3.1 billion by 2032. In 2021, gelatin softgel capsules will dominate the global market, with a share of about 75.3%, …
Continue reading “Softgel Capsules Market to reach a valuation of ~US$ 3.1 Billion by 2032”
Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031
[250 Pages Report] According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably, enabling the market to surpass US$ 14,471.2 Mn in valuation by the end of 2021. The market is forecast to exhibit 6.8% CAGR between 2021 and 2031. Ocular drug delivery systems are designed for dispensing drug, biologic, biopharmaceutical, and botanical …
Continue reading “Ocular Drug Delivery System Market sales will total US$ 27.82 Billion by 2031”
Pituitary stalk interruption syndrome treatment Market by registering a CAGR of 3.5% from 2023 to 2033
During the forecast period 2023-2033, the pituitary stalk interruption syndrome treatment market is expected to grow at a value of 3.5% CAGR, according to Future Market Insights. By the year 2033, the global market for pituitary stalk interruption syndrome treatment is expected to rise up to a market valuation of US$ 159.14 Million. Growth of the pituitary …
Rheumatic-Heart Disease Management Market is expected to be valued at US$ 1.31 Billion in 2023
The global Rheumatic-Heart Disease Management market size is expected to be valued at US$ 1.31 Billion in 2023. With the continuous improvements in drugs and biotechnology, the overall demand for Rheumatic-Heart Disease Management is projected to grow at a CAGR of 4.5% between 2023 and 2033, totaling around US$ 2.04 Billion by 2033. The rising prevalence of cardiovascular diseases globally is one of the major …
Heterozygous Familial Hypercholesterolemia (HEFH) Management Market to reach US$ 58.54 Billion by 2033 | FMI
In fiscal year 2023, the market for managing heterozygous familial hypercholesterolemia (HEFH) management is anticipated to be valued US$ 15.11 Billion, up from US$ 13.2 billion in fiscal year 2022. The worldwide market is anticipated to expand at a constant 14.5% CAGR from 2023 to 2033, reaching a value of US$ 58.54 Billion by the end of …
PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033 | FMI Report
A recently published study by FMI expects the global PCSK9 inhibitors market to augment at a 15.8% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 13 Billion is expected for the market. Monoclonal antibodies are a kind of biologic medicine that inhibits PCSK9. PCSK9 inhibitors bind to and …
Continue reading “PCSK9 Inhibitors Sales to expand at a 15.8% CAGR from 2023 to 2033 | FMI Report”
Hospitals dominate the Generic Injectable Services market as service providers | Says FMI Analyst
The Global Generic Injectable market research report contains critical information about the global, regional, and top players, such as Generic Injectable market share analysis, winning strategies, recent developments, and financial planning. Aside from providing information about the key players in the Generic Injectable market, the study also recalculates the impact of macroeconomic and microeconomic factors …
Oncolytic Virus Cancer Therapy Market growing at a whopping 27% CAGR: FMI Report
According to a recent study published by Future Market Insights, the market for oncolytic virus cancer therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have captured steps to raise awareness about …
Continue reading “Oncolytic Virus Cancer Therapy Market growing at a whopping 27% CAGR: FMI Report”